Philippe Camus, M.D.

Dijon, France

Both apps are now back!

Back to drug

The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XLIII.x

Obliterative bronchiolitis (a pattern consistent with) (see also IVn, XVx)

Publications

Solh M, Arat M, Cao Q, Majhail NS, Weisdorf D

Late-onset noninfectious pulmonary complications in adult allogeneic hematopoietic cell transplant recipients.

Transplantation 2011 Apr 15;91;798-803 — 2011 Apr 15 — 798-803

Afessa B, Litzow MR, Tefferi A

Bronchiolitis obliterans and other late onset non-infectious pulmonary complications in hematopoietic stem cell transplantation.

Bone marrow transplantation 2001 Sep;28;425-34 — 2001 Sep — 425-34

Worthy SA, Flint JD, Müller NL

Pulmonary complications after bone marrow transplantation: high-resolution CT and pathologic findings.

Radiographics : a review publication of the Radiological Society of North America, Inc 1997 Nov-Dec;17;1359-71 — 1997 Nov-Dec — 1359-71

Lentz D, Bergin CJ, Berry GJ, Stoehr C, Theodore J

Diagnosis of bronchiolitis obliterans in heart-lung transplantation patients: importance of bronchial dilatation on CT.

AJR. American journal of roentgenology 1992 Sep;159;463-7 — 1992 Sep — 463-7